Incyte Corp - Company Profile
Powered by
All the data and insights you need on Incyte Corp in one report.
- Save hours of research time and resources with
our up-to-date Incyte Corp Strategy Report
- Understand Incyte Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Incyte Corp (Incyte) discovers and develops proprietary small molecule drugs for the treatment of serious chronic inflammatory diseases and cancer. Focus on R&D and robust patent portfolio; marketed product Jakafi, and integrating acquisitons are its strengths even as confined geographical operations could be major causes for concern to the company. Incyte could benefit from regulatory approvals, orphan drug designation, and the strategic contracts and agreements. However, stiff competition, stringent government regulations, and lack of manufacturing facilities could affect the company's business.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward